Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Rubicon 14, 18 and 35 Support Catheters

K-Number: K171913 · 2017-07-25

ApplicantBoston Scientific Corporation
Decision Date2017-07-25
Product CodeDQY
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Rubicon 14, 18 and 35 Support Catheters is the device name listed in this FDA 510(k) record. The listed applicant is Boston Scientific Corporation. It received FDA 510(k) clearance on 2017-07-25 under 510(k) number K171913. The device is classified under product code DQY. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Rubicon 14, 18 and 35 Support Catheters?

Rubicon 14, 18 and 35 Support Catheters is a medical device that received FDA 510(k) clearance on 2017-07-25. The listed applicant is Boston Scientific Corporation. The 510(k) number is K171913.

When did Rubicon 14, 18 and 35 Support Catheters receive FDA 510(k) clearance?

Rubicon 14, 18 and 35 Support Catheters received FDA 510(k) clearance on 2017-07-25, under 510(k) number K171913.

Who is the listed applicant for Rubicon 14, 18 and 35 Support Catheters?

The FDA 510(k) record lists Boston Scientific Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Rubicon 14, 18 and 35 Support Catheters?

The FDA product code for Rubicon 14, 18 and 35 Support Catheters is DQY.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT01385176Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)ACTIVE_NOT_RECRUITINGNCT01550575Patient Retrospective Outcomes (PRO)RECRUITINGNCT01719055RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for PainRECRUITINGNCT02071134Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS RegistryRECRUITINGNCT02686125Vercise™ DBS Dystonia Prospective StudyRECRUITINGNCT02928497Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral AnticoagulationTERMINATED

Other records listing Boston Scientific Corporation as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K262406EluPro Antibiotic-Eluting BioEnvelopePMA P150031Stimulator, electrical, implanted, for parkinsonian symptomsPMA P030017Stimulator, spinal-cord, totally implanted for pain reliefPMA P190006Implanted electrical device intended for treatment of fecal incontinencePMA P180046Stimulator, electrical, implantable, for incontinencePMA P180011Stent, superficial femoral artery, drug-eluting

View all 251 devices →

Related Devices (Code: DQY)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K260559NHanceITIMDS Operation B.V.K262392APRO 35 Swift CatheterAlembic, LLCK262240SSPC NXT Delivery CatheterCenterPoint Systems, LLCK261766CPS Locator 3D Plus Delivery CatheterCenterPoint Systems, LLCK261825Amplatzer TorqVue LP Delivery System; Amplatzer TorqVue LP CatheterAbbottK261631Amplatzer TorqVue Exchange SystemAbbott Medical

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑